Not Signed In - 88 Percent Sensitivity For Colon Cancer Reported Using Non-Invasive Screening Test
Mon, 18 Dec 2006 02:00 PM EST
... Mount Sinai School of Medicine and EXACT Sciences Corporation (NASDAQ: EXAS) has announced the publication of results from a prospective, multi-center study of stool DNA testing. The study found that the test demonstrated an 88% sensitivity for colorectal cancer, and with equal detection across all stages of cancer, regardless of the cancer’s location in the colon. [click link for full article] ...
Related Topics
- Colon Cancer
- Colorectal Cancer
- Screening
- Colon Polyps
- Rectal Cancer
- Ovarian Cancer
- Bladder Cancer
- Cancers
- Prostate Cancer
- Multiple Chemical Sensitivity
- Liver Cancer
- Prenatal Screening
- CEA
- Clinical Laboratory Improvement Amendments
- Metastatic Cancer
- Hereditary nonpolyposis colorectal cancer
- Oral Cancer
- Testicular Cancer
- Pregnancy Test
- CRP
email this page
print this page
bookmark this page
feedback on this page
